Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 146.80
Ask: 148.20
Change: 5.80 (4.02%)
Spread: 1.40 (0.954%)
Open: 144.00
High: 150.00
Low: 143.00
Prev. Close: 144.20
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Apr 2018 12:47

RNS Number : 2605M
Apax Global Alpha Limited
26 April 2018
 

(LSE: APAX)

Apax Global Alpha Limited

 

Director Appointment

 

The Directors are pleased to announce that Mr Michael Bane has accepted an invitation to join the Board, as a non-executive Director and a member of its audit committee, with effect from 3 July 2018.

 

Mr Bane has more than 35 years of audit and advisory experience, in the asset management industry, including in relation to private equity funds. 

 

He has been resident in Guernsey for over 20 years, currently leading Ernst and Young's (EY) services to the asset management industry in the Channel Islands and is member of EY's EMEIA Wealth and Asset Management Board. Prior to EY, he was at PwC, in both London and Guernsey. Mr Bane will retire as a partner at EY on 29 June 2018.

 

Further information on Mr Bane will shortly be made available on the Company's website.

 

Mr Bane graduated with a BA in Mathematics, from the University of Oxford, and is a member of the Institute of Chartered Accountants, in England and Wales. Mr Bane has no other listed company directorships, other than HICL Infrastructure Company Limited, where it has been announced that he will join the board of that company with effect from 1 July 2018 and he (or any person that may be deemed a person closely associated to him), has no beneficial interest in the shares of the Company, as at the date of this announcement.

 

There are no further details required to be disclosed pursuant to section 9.6.13 of the UKLA Listing Rules.

 

Contact details

 

Investor relations

Sarah Wojcik

IR Manager - AGA

Telephone: +44 (0)20 7666 6573

Email: sarah.wojcik@apax.com

Media enquiries

Andrew Kenny

Head of Communications

Telephone: +44 (0)20 7872 6371

Email: andrew.kenny@apax.com

Company secretary

Jacques Colley

Client Relationship Manager

Telephone: +44 (0) 1481 749 700

Email: AGA-admin@aztecgroup.co.uk

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser".

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR").

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

 

 

 

 

About Apax Partners LLP

 

Apax Partners is a leading global private equity advisory firm and over its more than 35-year history, Apax Partners has raised and advised funds with aggregate commitments of over €42billion as at 31 December 2017. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUCCCUPRGGQ
Date   Source Headline
10th Sep 202011:39 amRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNS2020 Interim Dividend
25th Aug 20207:00 amRNS2020 Interim Report and Accounts
25th Aug 20207:00 amRNS2020 Interim Results Highlights
17th Aug 20207:00 amRNSInitial Public Offering of Duck Creek
10th Aug 20209:28 amRNSDirector Declaration - Additional Directorship
22nd Jul 20207:01 amRNSApax Fund Valuation Comments
22nd Jul 20207:00 amRNSApax Funds’ Valuations as at 30 June 2020
25th Jun 20207:00 amRNS2020 AGA Investor Update
17th Jun 20205:26 pmRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSNotice of Interim Results
11th Jun 20205:03 pmRNSDirector Declaration - Additional Directorship
9th Jun 202010:04 amRNSNotice of Investor Update
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:02 pmRNSPrice Monitoring Extension
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
1st Jun 202012:08 pmRNSSecond Price Monitoring Extn
1st Jun 202012:02 pmRNSPrice Monitoring Extension
28th May 202012:07 pmRNSSecond Price Monitoring Extn
28th May 202012:02 pmRNSPrice Monitoring Extension
27th May 20202:46 pmRNSDirector/PDMR Shareholding
27th May 20202:45 pmRNSDirector/PDMR Shareholding
22nd May 202012:15 pmRNSDirector/PDMR Shareholding
20th May 20204:36 pmRNSDirector/PDMR Shareholding
18th May 20203:38 pmRNSDirector/PDMR Shareholding
15th May 20207:00 amRNSQuarterly results for 31 March 2020
14th May 20205:29 pmRNSDirector Declaration - Additional Directorship
13th May 20207:00 amRNSApax Funds’ Valuations as at 31 March 2020
29th Apr 202012:32 pmRNSResult of AGM
29th Apr 202011:41 amRNSDisclosure of rights attached to equity shares
21st Apr 20201:12 pmRNSAGM Update
20th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:42 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:07 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
14th Apr 202012:08 pmRNSSecond Price Monitoring Extn
14th Apr 202012:03 pmRNSPrice Monitoring Extension
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:35 pmRNSPrice Monitoring Extension
1st Apr 202012:08 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSAGM Update
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20201:13 pmRNSNotice of Results
26th Mar 20201:12 pmRNSStatement regarding COVID-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.